2 years of historical data (2022–2023) · Healthcare · Drug Manufacturers - General
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
SRx Health Solutions Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 7.6x P/FCF.
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Market Cap | $9M | — | — |
| Enterprise Value | $36M | — | — |
| P/E Ratio → | -0.19 | — | — |
| P/S Ratio | 0.10 | — | — |
| P/B Ratio | — | — | — |
| P/FCF | 7.56 | — | — |
| P/OCF | 4.19 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| EV / Revenue | — | — | — |
| EV / EBITDA | — | — | — |
| EV / EBIT | — | — | — |
| EV / FCF | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
SRx Health Solutions Inc. earns an operating margin of -4.9%. Operating margins have compressed from -1.3% to -4.9% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Gross Margin | 19.9% | 19.9% | 14.4% |
| Operating Margin | -4.9% | -4.9% | -1.3% |
| Net Profit Margin | -9.4% | -9.4% | -2.6% |
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| ROE | — | — | -264.1% |
| ROA | -22.4% | -22.4% | -7.0% |
| ROIC | -18.1% | -18.1% | -5.1% |
| ROCE | -98.8% | -98.8% | -9.1% |
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $37M ($39M total debt minus $2M cash).
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Debt / Equity | — | — | 19.25 |
| Debt / EBITDA | — | — | — |
| Net Debt / Equity | — | — | 17.46 |
| Net Debt / EBITDA | — | — | — |
| Debt / FCF | — | 23.68 | 5.17 |
| Interest Coverage | -2.83 | -2.83 | -1.55 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.38x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.67x to 0.38x over the past 3 years.
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Current Ratio | 0.38 | 0.38 | 0.67 |
| Quick Ratio | 0.30 | 0.30 | 0.49 |
| Cash Ratio | 0.03 | 0.03 | 0.08 |
| Asset Turnover | — | 1.84 | 2.66 |
| Inventory Turnover | 16.67 | 16.67 | 19.75 |
| Days Sales Outstanding | — | 21.66 | 13.32 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
SRx Health Solutions Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Dividend Yield | — | — | — |
| Payout Ratio | — | — | — |
| Metric | TTM | FY 2023 | FY 2022 |
|---|---|---|---|
| Earnings Yield | — | — | — |
| FCF Yield | 13.2% | — | — |
| Buyback Yield | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | — | — |
| Shares Outstanding | — | $12M | $704183 |
Compare SRXH with 2 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| SRXHYou | $9M | -0.2 | — | 7.6 | 19.9% | -4.9% | — | -18.1% | — |
| NVS | $322B | 23.5 | 15.5 | 18.2 | 75.0% | 31.2% | 31.0% | 18.8% | 1.7 |
| OGN | $2B | 10.1 | 1.2 | — | 54.1% | 20.7% | 27.1% | 19.8% | — |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 2 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how SRXH stacks up against sector leader Novartis AG.
Start ComparisonSRx Health Solutions Inc.'s current P/E ratio is -0.2x. This places it at the 50th percentile of its historical range.
Based on historical data, SRx Health Solutions Inc. is trading at a P/E of -0.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
SRx Health Solutions Inc. has 19.9% gross margin and -4.9% operating margin.